# NewtekOne, Inc.: financial statements, quarterly

NEWT · Nasdaq · CIK 1587987 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/newt.md) · [Financials](/companies/newt/financials.md) · [Filings](/companies/newt/filings.md) · [Insiders](/companies/newt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/newt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [18.7](/filings/0001587987-24-000054.md) | [18.1 d](/filings/0001587987-24-000054.md) | [18.2](/filings/0001587987-24-000082.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.4](/filings/0001587987-24-000237.md) | [4.0 d](/filings/0001628280-26-016503.md) | [3.4](/filings/0001587987-25-000084.md) | [3.8](/filings/0001587987-25-000141.md) | [5.1](/filings/0001628280-25-050582.md) | [5.4 d](/filings/0001628280-26-016503.md) | [2.3](/filings/0001587987-26-000004.md) | [5.1](/filings/0001628280-26-055245.md) | [7.2](/filings/0001628280-25-050582.md) | [4.9 d](/filings/0001628280-26-016503.md) | [3.7](/filings/0001587987-26-000004.md) | [4.5](/filings/0001628280-26-055245.md) |
| Net income | $m | [10.9](/filings/0001587987-24-000237.md) | [10.8 d](/filings/0001628280-26-016503.md) | [9.7](/filings/0001587987-25-000084.md) | [10.9](/filings/0001587987-25-000141.md) | [11.9](/filings/0001628280-25-050582.md) | [18.3 d](/filings/0001628280-26-016503.md) | [9.4](/filings/0001587987-26-000004.md) | [13.7](/filings/0001628280-26-055245.md) | [17.9](/filings/0001628280-25-050582.md) | [19.5 d](/filings/0001628280-26-016503.md) | [13.4](/filings/0001587987-26-000004.md) | [14.6](/filings/0001628280-26-055245.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001587987-24-000237.md) | not reported | [0.38](/filings/0001587987-25-000084.md) | [0.43](/filings/0001587987-25-000141.md) | [0.45](/filings/0001628280-25-050582.md) | not reported | [0.35](/filings/0001587987-26-000004.md) | [0.52](/filings/0001628280-26-055245.md) | [0.67](/filings/0001628280-25-050582.md) | not reported | [0.43](/filings/0001587987-26-000004.md) | [0.47](/filings/0001628280-26-055245.md) |
| Basic EPS | $ per share | [0.43](/filings/0001587987-24-000237.md) | not reported | [0.38](/filings/0001587987-25-000084.md) | [0.43](/filings/0001587987-25-000141.md) | [0.45](/filings/0001628280-25-050582.md) | not reported | [0.36](/filings/0001587987-26-000004.md) | [0.53](/filings/0001628280-26-055245.md) | [0.68](/filings/0001628280-25-050582.md) | not reported | [0.43](/filings/0001587987-26-000004.md) | [0.48](/filings/0001628280-26-055245.md) |

- Revenue: not reported
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.6](/filings/0001587987-24-000237.md) | [15.4](/filings/0001587987-25-000050.md) | [12.3](/filings/0001587987-25-000084.md) | [36.9](/filings/0001587987-25-000141.md) | [9.7](/filings/0001628280-25-050582.md) | [6.9](/filings/0001628280-26-016503.md) | [10.2](/filings/0001587987-26-000004.md) | [10.1](/filings/0001587987-25-000141.md) | [4.0](/filings/0001628280-25-050582.md) | [4.2](/filings/0001628280-26-055245.md) | [5.2](/filings/0001587987-26-000004.md) | [5.2](/filings/0001628280-26-055245.md) |
| Total assets | $m | [1,393](/filings/0001587987-24-000237.md) | [1,430](/filings/0001628280-26-016503.md) | [1,510](/filings/0001587987-25-000084.md) | [1,617](/filings/0001587987-25-000141.md) | [1,674](/filings/0001628280-25-050582.md) | [2,060](/filings/0001628280-26-016503.md) | [2,137](/filings/0001587987-26-000004.md) | [2,126](/filings/0001628280-26-055245.md) | [2,399](/filings/0001628280-25-050582.md) | [2,745](/filings/0001628280-26-055245.md) | [2,887](/filings/0001587987-26-000004.md) | [3,185](/filings/0001628280-26-055245.md) |
| Total liabilities | $m | [1,151](/filings/0001587987-24-000054.md) | [1,180](/filings/0001587987-25-000050.md) | [1,255](/filings/0001587987-24-000082.md) | [1,343](/filings/0001587987-24-000168.md) | [1,392](/filings/0001587987-24-000237.md) | [1,764](/filings/0001628280-26-016503.md) | [1,834](/filings/0001587987-25-000084.md) | [1,814](/filings/0001587987-25-000141.md) | [2,012](/filings/0001628280-25-050582.md) | [2,347](/filings/0001628280-26-055245.md) | [2,482](/filings/0001587987-26-000004.md) | [2,772](/filings/0001628280-26-055245.md) |
| Long-term debt | $m | [649](/filings/0001587987-23-000225.md) | [644](/filings/0001587987-25-000050.md) | [662](/filings/0001587987-24-000082.md) | [652](/filings/0001587987-24-000168.md) | [656](/filings/0001587987-24-000237.md) | [708](/filings/0001628280-26-016503.md) | [774](/filings/0001587987-25-000084.md) | [657](/filings/0001587987-25-000141.md) | [749](/filings/0001628280-25-050582.md) | [820](/filings/0001628280-26-055245.md) | [550](/filings/0001587987-26-000004.md) | [554](/filings/0001628280-26-055245.md) |
| Shareholders' equity | $m | [242](/filings/0001587987-24-000237.md) | [249](/filings/0001628280-26-016503.md) | [254](/filings/0001587987-25-000141.md) | [274](/filings/0001628280-25-050582.md) | [282](/filings/0001628280-25-050582.md) | [296](/filings/0001628280-26-055245.md) | [302](/filings/0001628280-26-055245.md) | [312](/filings/0001628280-26-055245.md) | [387](/filings/0001628280-25-050582.md) | [398](/filings/0001628280-26-055245.md) | [405](/filings/0001628280-26-055245.md) | [413](/filings/0001628280-26-055245.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [101 d](/filings/0001587987-24-000237.md) | [(67.7) d](/filings/0001628280-26-016503.md) | [(38.7)](/filings/0001587987-25-000084.md) | [2.9 d](/filings/0001587987-25-000141.md) | [(25.7) d](/filings/0001628280-25-050582.md) | [(91.6) d](/filings/0001628280-26-016503.md) | [(60.7)](/filings/0001587987-26-000004.md) | [(200) d](/filings/0001628280-26-055245.md) | [(167) d](/filings/0001628280-25-050582.md) | [(151) d](/filings/0001628280-26-016503.md) | [(257)](/filings/0001587987-26-000004.md) | [(163) d](/filings/0001628280-26-055245.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001587987-24-000237.md) | [0.2 d](/filings/0001628280-26-016503.md) | [0.1](/filings/0001587987-25-000084.md) | [0.1 d](/filings/0001587987-25-000141.md) | [0.2 d](/filings/0001628280-25-050582.md) | [0.1 d](/filings/0001628280-26-016503.md) | [0.0](/filings/0001587987-26-000004.md) | [0.1 d](/filings/0001628280-26-055245.md) | [0.0 d](/filings/0001628280-25-050582.md) | [0.0 d](/filings/0001628280-26-016503.md) | [0.1](/filings/0001587987-26-000004.md) | [(0.0) d](/filings/0001628280-26-055245.md) |
| Dividends paid | $m | [4.8 d](/filings/0001587987-24-000237.md) | [4.8 d](/filings/0001628280-26-016503.md) | [4.8](/filings/0001587987-25-000084.md) | [5.0 d](/filings/0001587987-25-000141.md) | [5.2 d](/filings/0001628280-25-050582.md) | [5.2 d](/filings/0001628280-26-016503.md) | [5.2](/filings/0001587987-26-000004.md) | [5.2 d](/filings/0001628280-26-055245.md) | [5.7 d](/filings/0001628280-25-050582.md) | [11.9 d](/filings/0001628280-26-016503.md) | [6.5](/filings/0001587987-26-000004.md) | [6.5 d](/filings/0001628280-26-055245.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-25-050582.md) | [0.4 d](/filings/0001628280-26-016503.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-050582.md) | [(0.2) d](/filings/0001628280-26-016503.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.3](/filings/0001587987-23-000225.md) | [24.9](/filings/0001587987-24-000082.md) | [24.3](/filings/0001587987-24-000168.md) | [24.4](/filings/0001587987-24-000237.md) | [24.4](/filings/0001587987-25-000084.md) | [24.7](/filings/0001587987-25-000141.md) | [26.6](/filings/0001628280-25-050582.md) | [25.6](/filings/0001587987-26-000004.md) | [25.6](/filings/0001628280-26-055245.md) | [26.0](/filings/0001628280-25-050582.md) | [28.7](/filings/0001587987-26-000004.md) | [28.7](/filings/0001628280-26-055245.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,884,731 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055245.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.